knowledge -WSS

knowledge

author：explore 2025-10-01 21:37:04 - browse：34456

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Bernie Sanders bashes nonprofit hospitals over their tax breaks

Wikipedia

WSS

Life sciences deals on track to hit lowest point since 2017

Parkland mass shooting to be reenacted for lawsuit

Calls for Trump's election interference trial to be televised part of long debate

Life sciences deals on track to hit lowest point since 2017

STAT Readout: Today's biotech news includes Sana and Amylyx

Medical mystery: When an infection after surgery isn’t what it seems

Wikipedia

knowledge

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Lifetime voting ban for felony convictions struck down in Mississippi

Bright Health sells Medicare Advantage business to Molina

A revolution in caring for preterm infants

What does generative AI mean for health care? We asked experts

Medicare to cover more brain scans related to Alzheimer’s drugs

Walensky prepares to leave CDC — and Congress — behind

Humana CEO Bruce Broussard to step down in 2024

In age of alternative facts, a scholarly course on calling out crap

Readout LOUD podcast: Merger Mondays, Ozempic panic

explore

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

What's changing in Medicare's open enrollment this year?

European regulators recommend Amylyx's ALS drug be rejected

Russian court extends detention of American musician

European regulators consider appeal over Amylyx ALS drug

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

focus

focus

Wikipedia

leisure time